Glatiramer Pregnancy and Breastfeeding Warnings

Glatiramer is also known as: Copaxone

Glatiramer Pregnancy Warnings

Although these events were not controlled, pregnancy occurred in three women during a clinical trial of glatiramer, and two of these women elected to discontinue therapy and subsequently delivered normal infants. The length of time that glatiramer was used after conception was not reported. One woman chose to have a therapeutic abortion and continued the study.

Glatiramer acetate has been assigned to pregnancy category B by the FDA. Animal studies failed to reveal teratogenic effects. There are no adequate and well-controlled studies in pregnant women. Glatiramer acetate should only be given during pregnancy when benefit outweighs risk.

Glatiramer Breastfeeding Warnings

There are no data on the excretion of glatiramer into human milk.

See Also...

• Glatiramer use while Breastfeeding (in more detail)
• glatiramer Consumer Information
• Pregnancy Support Group
• FDA Pregnancy Categories
• Medicine use during Pregnancy
• Medicine use while Breastfeeding
• Safe Medications during Breastfeeding

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.